Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (311-320 of 1,859) with videos related to

Pageof 186
Sort By:
Journal of Clinical Pharmacology|May 1, 1990
Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonismW H Frishman, S Covey
The American Journal of Medicine|February 14, 2012
The closing of St Vincent's Hospital in New York City: what happened to the house staff orphans?Elizabeth Zheng, William H Frishman
Cardiology in Review|March 27, 2012
Cardiac and pericardial tumorsGurpreet Lamba, William H Frishman
Cardiology in Review|February 27, 2020
Diastolic Heart Failure: A Review of Current and Future Treatment OptionsDon Goldstein, William H Frishman
The American Journal of Cardiology|October 1, 1982
Verapamil therapy for stable and unstable angina pectoris: calcium channel antagonists in perspectiveM Packer, W H Frishman
Cardiology in Review|July 2, 2025
Pompe Disease: Current State and Future TreatmentsMargot Richards, William H Frishman
Cardiology in Review|September 18, 2025
Beyond Glycemic Control: Glucagon-Like Peptide-1 Receptor Agonists as Potential Modifiers of Aortic DiseaseKanwardeep Singh, William H Frishman
Cardiology in Review|September 15, 2025
Management of Atrial Septal Defect in the Adult PopulationRhea Munjal, William H Frishman
Cardiology in Review|December 6, 2013
Air pollution exposure as a risk factor for cardiovascular disease morbidity and mortalityAnna Koulova, William H Frishman
Cardiology in Review|May 28, 2013
Newer therapeutic strategies to alter high-density lipoprotein level and functionNicholas Bosch, William H Frishman
Pageof 186

Showing results (311-320 of 1,859) with videos related to

Sort By:
Pageof 186
Journal of Clinical Pharmacology|May 1, 1990
Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonismW H Frishman, S Covey
The American Journal of Medicine|February 14, 2012
The closing of St Vincent's Hospital in New York City: what happened to the house staff orphans?Elizabeth Zheng, William H Frishman
Cardiology in Review|March 27, 2012
Cardiac and pericardial tumorsGurpreet Lamba, William H Frishman
Cardiology in Review|February 27, 2020
Diastolic Heart Failure: A Review of Current and Future Treatment OptionsDon Goldstein, William H Frishman
The American Journal of Cardiology|October 1, 1982
Verapamil therapy for stable and unstable angina pectoris: calcium channel antagonists in perspectiveM Packer, W H Frishman
Cardiology in Review|July 2, 2025
Pompe Disease: Current State and Future TreatmentsMargot Richards, William H Frishman
Cardiology in Review|September 18, 2025
Beyond Glycemic Control: Glucagon-Like Peptide-1 Receptor Agonists as Potential Modifiers of Aortic DiseaseKanwardeep Singh, William H Frishman
Cardiology in Review|September 15, 2025
Management of Atrial Septal Defect in the Adult PopulationRhea Munjal, William H Frishman
Cardiology in Review|December 6, 2013
Air pollution exposure as a risk factor for cardiovascular disease morbidity and mortalityAnna Koulova, William H Frishman
Cardiology in Review|May 28, 2013
Newer therapeutic strategies to alter high-density lipoprotein level and functionNicholas Bosch, William H Frishman
Pageof 186